Quantbot Technologies LP Catalyst Pharmaceuticals, Inc. Transaction History
Quantbot Technologies LP
- $2.88 Billion
- Q1 2025
A detailed history of Quantbot Technologies LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 16,679 shares of CPRX stock, worth $357,931. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,679
Previous 11,237
48.43%
Holding current value
$357,931
Previous $234,000
72.65%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding CPRX
# of Institutions
390Shares Held
100MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$401 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$182 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$119 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$73.4 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$67.3 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.21B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...